Future of Biomanufacturing: Why Single-Use Bioreactors Are Transforming the Biotech Landscape
In the fast-evolving world of biotechnology, flexibility and efficiency are everything. As biopharma companies race to develop new vaccines, biosimilars, and cell-based therapies, they need manufacturing systems that can keep pace with innovation. That’s where single-use bioreactors (SUBs) are changing the game — offering a faster, cleaner, and more sustainable way to produce biologics at scale.
According...
Drug Device Combination Products Market Size, Trends, and Forecast to 2030
The global drug device combination products market is poised for substantial growth, projected to reach USD 379.17 billion by 2030 from USD 243.02 billion in 2025, expanding at a CAGR of 9.3% during the forecast period. This rapid expansion is primarily attributed to the rising global burden of chronic diseases such as diabetes, cardiovascular conditions, and cancer, along with the growing geriatric...
Pharmaceutical Packaging Equipment Market Outlook 2030: Trends, Drivers, and Strategic Growth Opportunities
ity, reinforcing global demand for efficient, automated, and validated packaging solutions.
Download PDF Brochure
Key Factors Driving the Pharmaceutical Packaging Equipment Market
1. Rising Demand for Regulatory Compliance and Serialization
Global pharmaceutical regulations such as the FDA’s 21 CFR Part 11, EU Falsified Medicines Directive (FMD), and the US Drug Supply Chain Security...
Veterinary Vaccines Market to Reach USD 13.33 Billion by 2029
The global Veterinary Vaccines Market, valued at USD 8.93 billion in 2023, is projected to grow at a CAGR of 6.1%, reaching USD 9.39 billion in 2024 and USD 13.33 billion by 2029, according to MarketsandMarkets.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1233
Key Market Drivers
Companion Animal Growth – The surge in pet ownership, particularly dogs...
Single-Use Bioreactors: Powering the Growth of the Biologics Industry
The biologics industry is at the forefront of medical innovation, driving breakthroughs in vaccines, monoclonal antibodies, cell and gene therapies, and recombinant proteins. As demand for biologics continues to surge, the need for flexible, scalable, and cost-efficient manufacturing systems has become more pressing than ever. Enter the single-use bioreactor (SUB) — a technology that is...
Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Poised to Reach USD 14.8 Billion by 2029 Amid Advances in Precision Diagnostics and AI-Driven Genomics
The Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is projected to grow from USD 10.0 billion in 2024 to USD 14.8 billion by 2029, registering a robust CAGR of 8.1% during the forecast period. Growth is fueled by the increasing prevalence of infectious diseases and genetic disorders, rapid technological advancements in PCR platforms, and the surging demand...
Contrast Media Market Set for Strong Growth with Rising Diagnostic Imaging Demand
The global contrast media market is witnessing significant expansion, driven by the increasing volume of diagnostic imaging procedures, rising prevalence of chronic diseases, and advancements in imaging technologies such as CT, MRI, and ultrasound.
The global contrast media market, valued at US$5.9 billion in 2022, stood at US$6.3 billion in 2023 and is projected to advance at a resilient CAGR...
GLP-1 Analogues Market Set for Rapid Expansion in Diabetes & Obesity Treatment
The global GLP-1 analogues market is experiencing tremendous growth, driven by the increasing prevalence of metabolic disorders and the rising adoption of innovative therapies. The global GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period. Factors such as increasing manufacturing capacities and capabilities...
Autoinjectors Market Expands as Self-Administration and Drug Delivery Innovation Rise
The global Autoinjectors Market is witnessing strong growth, driven by the increasing demand for self-administrable drug delivery systems and the rising prevalence of chronic diseases such as diabetes, rheumatoid arthritis, and multiple sclerosis. The global autoinjectors market, valued at US$1.08 billion in 2023, stood at US$1.40 billion in 2024 and is projected to advance at a resilient CAGR of...
Healthcare Workforce Management Systems: Transforming Efficiency in Healthcare Operations
The global healthcare workforce management systems market is witnessing strong growth, projected to reach USD 2.8 billion by 2029, up from USD 1.7 billion in 2024, growing at a CAGR of 10.1% during the forecast period. This rapid expansion is primarily driven by the growing need to reduce healthcare costs through effective workforce management, the adoption of advanced digital tools, and the increasing...